Financial Data and Key Metrics Changes - Free cash flow for 2025 was reported at -$88 million, indicating a need for improvement in cash generation [4] - The company carries high-cost debt, which is unsustainable under current conditions [4] Business Line Data and Key Metrics Changes - In the Cellulose Specialties segment, 85% of the business has achieved an average price increase of 18% over 2025, with an expected volume loss of about 20% [5] - The remaining 15% of the specialties business is still under discussion for potential price increases [5][6] Market Data and Key Metrics Changes - The ethers-grade cellulose market is facing challenges due to increased competition from Chinese producers, particularly in Europe, but the company has still managed to achieve near 20% price increases [26] - The nitration-grade cellulose market is experiencing increased demand from domestic producers of propellants, with price increases exceeding 18% [27] Company Strategy and Development Direction - The company aims to deliver positive free cash flow in 2026 as a top priority [5] - A focus on asserting leadership in Cellulose Specialties and improving EBITDA across all business lines is emphasized [6][8] - The company plans to implement a more integrated model across its product lines to optimize contribution margins and drive down fixed costs [51] Management's Comments on Operating Environment and Future Outlook - Management expresses confidence in the team's ability to drive free cash flow and improve operational performance [11] - There is a recognition of the need for higher pricing to ensure the sustainability of domestic producers in the Cellulose Specialties market [12][13] - The company is actively working on plans to enhance its Biomaterials segment, which is seen as a key growth area [32] Other Important Information - The company has a crisis management team in place to address production issues at the Tartas plant, which is crucial for the Biomaterials business [34] - There are ongoing antidumping cases that could positively impact pricing in North America, with preliminary determinations expected soon [36][37] Q&A Session Summary Question: Confidence in underlying earnings power and long-term shareholder value - Management highlights the team's capability and the significant value opportunities within the company, with plans to provide more details in future earnings calls [11] Question: Perspective on rejected potential offer and independent company strategy - Management refrains from commenting on specific offers but emphasizes plans that will deliver more value as an independent company [19] Question: Demand conditions and market competition - Management acknowledges challenges in the ethers-grade cellulose market due to competition but notes successful price increases [26] Question: Strategy for Biomaterials and impact on BioNova joint venture - Management views Biomaterials as an important growth contributor and plans to integrate it with other product lines for better value creation [32] Question: Pricing restoration timeline and antidumping case updates - Management is optimistic about restoring prices with or without antidumping duties, with preliminary determinations expected soon [36] Question: Long-term role of Paperboard and High-Yield Pulp businesses - Management states that all business segments are sources of improvement and will not be divested, with new products expected to drive growth [42]

Rayonier Advanced Materials (NYSE:RYAM) Q4 2025 Earnings call March 04, 2026 09:00 AM ET Speaker5Good morning, and welcome to the RYAM fourth quarter 2025 earnings conference call. During today's presentation, all parties will be in a listen-only mode. Following the presentation, the conference will be open to questions with instructions to follow at that time. As a reminder, this conference is being recorded. I'd now like to turn the call over to your host, Mickey Walsh, Treasurer and Vice President of Inv ...